Class / Patent application number | Description | Number of patent applications / Date published |
514298000 | Phenanthridines (including hydrogenated) | 13 |
20080234312 | Feed or Feed Additive Containing an Alkaloid - The invention relates to a feed containing conventional feed substances, or feed additives for producing said feed. According to the invention, the feed or fed additive contains a protopine alkaloid, in particular α-allocryptopine, preferably in combination with at least one benzophenanthridine alkaloid in an active quantity as a stimulant and appetite enhance for commercial animals. | 09-25-2008 |
20090170892 | 3-Hydroxy-6-phenylphenanthridines as pde4 inhibitors - The compounds of formula I | 07-02-2009 |
20100035913 | Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiestrase (PDE) 4 inhibitors - The compounds of a certain formula (1), | 02-11-2010 |
20100190818 | Novel salts of 6-heterocycle substituted hexahydrophenanthridine derivatives - The invention relates to salts of 6-heteroaryl substituted hexahydrophenanthridine PDE4 inhibiting compounds, which can be used in the pharmaceutical industry for the production of pharmaceutical composition for use, e.g., in treatment of airway disorders. | 07-29-2010 |
20110124673 | 6-ALKENYL AND 6-PHENYLALKYL SUBSTITUTED 2-QUINOLINONES AND 2-QUINOXALINONES AS POLY(ADP-RIBOSE) POLYMERASE INHIBITORS - The present invention provides compounds of formula (I) and compounds of formula (VII-a) as well as pharmaceutical compositions comprising said compounds and their use as PARP inhibitors | 05-26-2011 |
20110257221 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS - Compounds of the formula Ia***** | 10-20-2011 |
20120122916 | SCREENING MOLECULES WITH ANTI-PRION ACTIVITY: KITS, METHODS AND SCREENED MOLECULES - The invention concerns screening molecules with anti-prion activity. More particularly, it concerns kits for screening molecules with anti-prion activity characterized in that they comprise in combination a [PSI+], phenotype yeast, an antibiogram and an agent for purifying prions at sub-efficient doses, said yeast including the ade1-14 allele of the ADE1 gene and an inactivated ERG6 gene, the screening methods, and a family of molecules with anti-prion activity isolated by the inventive screen. The invention is applicable to anti-prion agents for producing medicines in particular for treating neurodegenerative diseases involving protein aggregates. | 05-17-2012 |
20120122917 | Method For Treatment Of HIV And Diseases Of Immune Dysregulation - This invention discloses cannabinoid derivatives and pharmaceutical uses thereof. | 05-17-2012 |
20130096152 | NOVEL SALTS OF 6-HETEROCYCLE SUBSTITUTED HEXAHYDROPHENANTHRIDINE DERIVATIVES - Disclosed herein are salts of 6-heteroaryl substituted hexahydrophenanthridine PDE4 inhibiting compounds, which can be used in the pharmaceutical industry for the production of pharmaceutical compositions. | 04-18-2013 |
20130203801 | TREATMENT OF ADDICTION - The invention discloses methods for preventing or treating addiction by administering to a subject in need thereof a PARP inhibitor. | 08-08-2013 |
20140039001 | NOVEL SALTS OF 6-HETEROCYCLE SUBSTITUTED HEXAHYDROPHENANTHRIDINE DERIVATIVES - Disclosed herein are salts of 6-heteroaryl substituted hexahydrophenanthridine PDE4 inhibiting compounds, which can be used in the pharmaceutical industry for the production of pharmaceutical compositions. | 02-06-2014 |
20150352096 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS - Compounds of the formula Ia***** | 12-10-2015 |
20160083364 | Phenanthridine Derivatives, Preparation Methods and Uses Thereof - The present invention relates to the pharmaceutical field, in particular to a phenanthridine derivative as shown in general formula (1) | 03-24-2016 |